According to Veru's latest financial reports the company's current revenue (TTM) is $15.92 M. In 2022 the company made a revenue of $27.72 M a decrease over the years 2021 revenue that were of $60.77 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $15.92 M | -42.55% |
2022 | $27.72 M | -54.38% |
2021 | $60.77 M | 30.34% |
2020 | $46.63 M | 29.5% |
2019 | $36 M | 83.26% |
2018 | $19.64 M | 51.17% |
2017 | $12.99 M | -24.16% |
2016 | $17.14 M | -49.85% |
2015 | $34.17 M | 39.73% |
2014 | $24.45 M | -13.38% |
2013 | $28.23 M | -22.23% |
2012 | $36.3 M | 54.19% |
2011 | $23.54 M | 15.52% |
2010 | $20.38 M | -26.38% |
2009 | $27.68 M | 9.68% |
2008 | $25.24 M | 21.04% |
2007 | $20.85 M | 33.56% |
2006 | $15.61 M | 18.68% |
2005 | $13.15 M | 61.87% |
2004 | $8.12 M | -10.97% |
2003 | $9.13 M | 1.56% |
2002 | $8.99 M | 25.34% |
2001 | $7.17 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.86 B | 5,320.59% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | -98.58% | ๐บ๐ธ USA |